Dermatologic Surgery最新文献_第2页

Dermatologic Surgery Trends in the Past Decade, 2014 to 2024: A Cross-Sectional Study. 2014年至2024年过去十年皮肤外科趋势：一项横断面研究。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-12 DOI: 10.1097/DSS.0000000000005385

Maya Akbik, Jordan Lim

{"title":"Dermatologic Surgery Trends in the Past Decade, 2014 to 2024: A Cross-Sectional Study.","authors":"Maya Akbik, Jordan Lim","doi":"10.1097/DSS.0000000000005385","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005385","url":null,"abstract":"Background: Dermatologic surgery research has expanded significantly, but comprehensive analysis of recent publication trends is needed to guide future priorities.Objective: The aim of this study was to analyze publication trends in dermatologic surgery from 2014 to 2024, examining volume, article types, geographic distribution, and journal outlets.Methods: A PubMed search identified publications using \"dermatology\" and \"surgery,\" filtered for English-language human studies including clinical trials, letters, meta-analyses, randomized controlled trials (RCTs), and systematic reviews. Linear regression evaluated temporal trends (p < .05).Results: Among 8,245 publications across 696 journals, volume peaked at 1,078 articles in 2020 before declining to 572 in 2023. Meta-analyses, RCTs, and systematic reviews increased significantly, with strong correlations for meta-analyses (R2 = 76.3%) and systematic reviews (R2 = 90.2%). Top journals included Dermatologic Surgery (n = 1,390), JEADV (n = 1,294), and JAAD (n = 1,224). Research spanned 58 countries, led by the United States.Conclusion: Dermatologic surgery shows robust growth in evidence-based research, although postpandemic declines and geographic disparities warrant attention to sustain momentum and global collaboration.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Staged Margin Assessment in Cutaneous Cancers: A Scoping Review. 分期边缘评估在皮肤癌：范围回顾。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-09 DOI: 10.1097/DSS.0000000000005375

Jay Patel, Ellen Chinchilli, Ella Engels, Franki Lambert Smith

{"title":"Staged Margin Assessment in Cutaneous Cancers: A Scoping Review.","authors":"Jay Patel, Ellen Chinchilli, Ella Engels, Franki Lambert Smith","doi":"10.1097/DSS.0000000000005375","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005375","url":null,"abstract":"Background: Large or very deep tumors may pose challenges for Mohs micrographic surgery when affecting functionally complex areas. Staged margin assessment techniques may be applied in these cases.Objective: To characterize staged margin assessment techniques in cutaneous malignancies and describe reported outcomes (local recurrence rate and follow-up duration).Materials and methods: This scoping review sought to include articles describing staged surgical techniques with separate steps for (1) analysis of peripheral margins using excision or Mohs surgery with en face sectioning and (2) excision of the remaining, central tumor with traditional vertical sectioning.Results: Among the 6,202 articles identified, 27 were included. Most studies (85.2%) were case based with tumor types consisting of melanoma in situ (65.7%), melanoma (19.7%), extramammary Paget disease (5.4%), dermatofibrosarcoma protuberans (4.9%), and keratinocyte malignancies (1.9%). Staged margin assessment methodology varied between studies; 41% of the studies specified interdisciplinary central debulking, most commonly with plastic surgery.Conclusion: Low levels of evidence supported staged margin assessment techniques. The methodology was diverse and applied to a variety of cutaneous malignancies, allowing for peripheral tumor clearance followed by interdisciplinary central debulking if traditional Mohs surgery was not feasible.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dermal Fillers in Skin of Color: Safety Considerations, Cultural Perspectives, and Patient-Centered Approaches. 有色皮肤的真皮填充物：安全考虑、文化观点和以病人为中心的方法。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-09 DOI: 10.1097/DSS.0000000000005383

Amanda U Nwaopara, Andrew F Alexis, Cheryl M Burgess

{"title":"Dermal Fillers in Skin of Color: Safety Considerations, Cultural Perspectives, and Patient-Centered Approaches.","authors":"Amanda U Nwaopara, Andrew F Alexis, Cheryl M Burgess","doi":"10.1097/DSS.0000000000005383","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005383","url":null,"abstract":"Background: Patients with skin of color make up a growing share of aesthetic dermatology practice, yet evidence guiding filler treatment in this population remains limited.Objective: To review the evidence on dermal filler treatment in patients with skin of color, emphasizing safety, treatment planning, and patient-centered care.Methods and materials: A narrative review of PubMed/MEDLINE was performed, focusing on filler safety and efficacy in Fitzpatrick skin types (FST) IV-VI, biologic characteristics of skin of color, and population-specific aesthetic considerations.Results: Hyaluronic acid fillers have the strongest evidence base in higher Fitzpatrick phototypes; biostimulatory fillers, particularly calcium hydroxylapatite, show favorable safety data, although evidence remains limited for poly-l-lactic acid. Key considerations include increased risk of postinflammatory hyperpigmentation, differences in recognizing vascular occlusion, and a theoretical, not clinically observed, predisposition to hypertrophic scarring and keloid formation. Treatment goals are often shaped by patient preferences regarding ethnic preservation and facial identity.Conclusion: Dermal filler treatment in patients with skin of color can be performed safely and effectively when guided by an understanding of melanin-rich skin biology, population-specific aging patterns, and patient-defined aesthetic goals; additional studies in higher Fitzpatrick phototypes are needed.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Randomized, No-Treatment-Controlled Study to Evaluate Effectiveness and Safety of SB-NASHA Injectable Gel for Décolletage Wrinkle Correction. 一项随机、无治疗对照研究评估SB-NASHA注射凝胶矫正臀臀皱纹的有效性和安全性。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-09 DOI: 10.1097/DSS.0000000000005381

Amir Moradi, Sabrina Fabi, Sachin M Shridharani, Joely Kaufman-Janette, Robyn Siperstein, Younghoon R Cho, Theda C Kontis, Keith Marcus, Tiffani Hamilton, Charlotta Wolgast, Felipe Weinberg, Matthew Meckfessel, Daniel Bråsäter

{"title":"A Randomized, No-Treatment-Controlled Study to Evaluate Effectiveness and Safety of SB-NASHA Injectable Gel for Décolletage Wrinkle Correction.","authors":"Amir Moradi, Sabrina Fabi, Sachin M Shridharani, Joely Kaufman-Janette, Robyn Siperstein, Younghoon R Cho, Theda C Kontis, Keith Marcus, Tiffani Hamilton, Charlotta Wolgast, Felipe Weinberg, Matthew Meckfessel, Daniel Bråsäter","doi":"10.1097/DSS.0000000000005381","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005381","url":null,"abstract":"Background: SB-NASHA is an injectable hyaluronic acid product for aesthetic treatment, shown to improve skin-quality parameters (such as hydration) and fine lines.Objective: The aim of this randomized, evaluator-blinded, no-treatment-controlled, multicenter study was to evaluate the effectiveness and safety of SB-NASHA for the correction of décolletage wrinkles.Patients and methods: Subjects with moderate-to-severe wrinkles on the Galderma Décolletage Scale (GDS) were randomized 3:1 to the SB-NASHA group or no-treatment group. The study was divided into 2 stages with similar treatment and follow-up periods.Results: In total, over both stages, 192 subjects were randomized to the SB-NASHA group (n = 144) or no-treatment group (n = 48). An additional 19 subjects with Fitzpatrick skin type (FST) V-VI were treated without randomization and included only in the safety population. The GDS responder rate was statistically significantly higher with SB-NASHA versus no treatment at Week 12 (73.6% vs 18.8%, respectively; primary end point), Week 24 (86.9% vs 34.9%), and Week 32 (80.8% vs 40.9%); all p < .001. GAIS improvement rates assessed by the treating investigator were higher for SB-NASHA versus no treatment at Week 12, Week 24, and Week 32 in both stages. All AEs related to study product or injection procedure were mild/moderate in intensity.Conclusion: Treatment of the wrinkles in décolletage area with SB-NASHA was effective and well tolerated.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Periprocedural Anesthesia and Analgesia in Hair Transplantation: An Evidence-Based Review of Contemporary Clinical Practice. 毛发移植围手术期麻醉和镇痛：当代临床实践的循证回顾。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-09 DOI: 10.1097/DSS.0000000000005387

Samuel Tringali

{"title":"Periprocedural Anesthesia and Analgesia in Hair Transplantation: An Evidence-Based Review of Contemporary Clinical Practice.","authors":"Samuel Tringali","doi":"10.1097/DSS.0000000000005387","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005387","url":null,"abstract":"Background: Hair transplantation is a widely performed office-based aesthetic procedure characterized by prolonged procedural duration, cumulative local anesthetic exposure, and reliance on sustained patient cooperation. Despite extensive literature on surgical technique and aesthetic outcomes, periprocedural anesthetic and analgesic considerations remain comparatively undersynthesized.Objective: The aims of this study were to review periprocedural anesthesia and analgesia strategies in hair transplantation and highlight practical considerations related to patient safety, procedural workflow, and intraoperative management.Materials and methods: A structured literature review was conducted using PubMed/MEDLINE and Embase from database inception through January 2026. Studies evaluating anesthetic techniques, analgesic strategies, periprocedural pain management, and anesthesia-related safety considerations in hair transplantation and comparable office-based dermatologic surgical procedures were included. Evidence was synthesized qualitatively according to predefined clinical domains.Results: Available evidence supports multimodal anesthetic strategies incorporating individualized local anesthetic selection, tumescence, regional nerve blocks, adjunctive analgesia, and structured intraoperative monitoring to optimize patient comfort, procedural efficiency, and safety. However, available evidence consists predominantly of observational studies, case series, and expert consensus, with limited high-quality comparative data.Conclusion: Individualized multimodal anesthetic strategies represent the current evidence-informed approach to periprocedural management in hair transplantation. Prospective comparative studies are needed to strengthen the evidence base and inform future clinical recommendations.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Differences in State-Level Oversight and Advertising by Nonphysician Providers. 非医师提供者在州级监督和广告方面的差异。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-08 DOI: 10.1097/DSS.0000000000005153

David Baltazar, Christopher Cullison, Katherine Given, Kimberly Breglio, Bryan Carroll

引用次数: 0

The Diluent Dilemma: Investigating Hypersensitivity in Bacteriostatic Botulinum Toxin Preparations. 稀释剂困境：研究抑菌肉毒杆菌毒素制剂的超敏反应。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-07 DOI: 10.1097/DSS.0000000000005377

Charlotte P O M van den Berg, Tom S Decates, Thomas Rustemeijer

引用次数: 0

Repair of a Combined Nasal Sidewall, Ala, and Lateral Tip Defect. 鼻侧壁、鼻翼和鼻尖联合缺损的修复。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-06 DOI: 10.1097/DSS.0000000000005355

Melanie S Jun, Kevin Y Shi

引用次数: 0

Central Tumor Debulking in Mohs Micrographic Surgery: Technical Variations, Staging Utility, and Operational Efficiency. Mohs显微摄影手术中枢性肿瘤减积：技术变化、分期、效用和操作效率。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-02 DOI: 10.1097/DSS.0000000000005372

Daniel J Lewis

{"title":"Central Tumor Debulking in Mohs Micrographic Surgery: Technical Variations, Staging Utility, and Operational Efficiency.","authors":"Daniel J Lewis","doi":"10.1097/DSS.0000000000005372","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005372","url":null,"abstract":"Background: Central tumor debulking typically precedes the initial stage in Mohs micrographic surgery (MMS) to facilitate tissue flattening and optimize margin evaluation.Objective: This review evaluates technical variations in debulking regarding tactile feedback, artifacts, laboratory processing, efficiency, and vertical staging.Materials and methods: A structured search of MEDLINE and Scopus was conducted for literature published through June 2026.Results: Blunt curettage provides tactile feedback but leaves residual tumor in 76.0% of cases, creates jagged edges, and increases the risk of floaters. Sharp scalpel excision preserves vertical architecture for vertical staging and identifying high-risk features. Tangential shaving is well suited for superficial tumors on convex-site contours. Ex vivo debulking avoids jagged edges on complex free-margin sites. Omitting debulking preserves architectural continuity throughout the lesion depth but predisposes the specimen to splaying and chattering artifacts as well as missing epidermal edges. Only 81.9% to 85.4% of Mohs surgeons routinely perform a debulk when treating melanoma in situ, despite clear consensus guidelines and established vertical upstaging rates ranging from 2.3% to 8.1%.Conclusion: Technical variations in debulking directly affect the final slide quality, processing efficiency, and staging accuracy. Tailoring the debulking modality to specific tumor histology and anatomic site is essential to optimize both surgical efficacy and laboratory workflow.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effectiveness and Safety of a High G' Hyaluronic Acid Injectable for Jawline Definition: A Randomized Controlled Clinical Investigation. 高G透明质酸注射用于下颌轮廓的有效性和安全性：一项随机对照临床研究。

IF 2.3 3区医学

Dermatologic Surgery Pub Date : 2026-10-02 DOI: 10.1097/DSS.0000000000005378

Sachin M Shridharani, Glynis Ablon, Oscar Hevia, Robert Weiss, John Joseph, Jose R Montes, Kyle Coleman, Alexander Donath, Rosalyn George, Brian Biesman, Rod Rohrich, Joel L Cohen, Michael Somenek, Leslie Baumann, Sue E Cox, Anna Nilsson, Annika Rugheimer, Felipe Weinberg, Torun Bromée

{"title":"Effectiveness and Safety of a High G' Hyaluronic Acid Injectable for Jawline Definition: A Randomized Controlled Clinical Investigation.","authors":"Sachin M Shridharani, Glynis Ablon, Oscar Hevia, Robert Weiss, John Joseph, Jose R Montes, Kyle Coleman, Alexander Donath, Rosalyn George, Brian Biesman, Rod Rohrich, Joel L Cohen, Michael Somenek, Leslie Baumann, Sue E Cox, Anna Nilsson, Annika Rugheimer, Felipe Weinberg, Torun Bromée","doi":"10.1097/DSS.0000000000005378","DOIUrl":"https://doi.org/10.1097/DSS.0000000000005378","url":null,"abstract":"Background: HASHA is a novel, NASHA HD Technology, hyaluronic acid (HA) injectable, optimized for lower-face shaping.Objectives: This multicenter study evaluated effectiveness and safety of HASHA in improving jawline definition for up to 2 years.Methods: Subjects with moderate-to-very-severe volume deficiency on the Galderma Jawline Scale (GJS) were randomized 3:1 to HASHA injections (via needle or cannula) or no-treatment control. At Month 12, HASHA-treated subjects were offered optional re-treatment and controls were offered first treatment with HASHA.Results: At Month 3, the HASHA group (N = 168) had a statistically significant (p < .001) higher ≥1-grade blinded evaluator-assessed GJS responder rate than the no-treatment group (N = 68) (85.1% vs 14.3%, primary endpoint), which remained high in the HASHA group at Months 12 (67.1%) and 24 (69.0% without re-treatment; 81.3% with Month-12 re-treatment). Treating-investigator-assessed Global Aesthetic Improvement Scale improvement rates were ≥84% at Months 3 to 24. Most HASHA-treated subjects reported improved overall satisfaction with their appearance (≥70%) and natural-looking results (≥82%) through Month 24. Treatment-related adverse events, all mild or moderate, occurred in 14.5% of subjects after initial treatment.Conclusion: HASHA was superior to no-treatment for improving jawline definition, with improvement lasting throughout 24 months. Subject satisfaction was high. Treatment was well tolerated.","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0